Multicenter Phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma
-
- SUGIURA HIDESHI
- Department of Orthopaedic Surgery, Aichi Cancer Center Hospital
-
- FUJIWARA YASUHIRO
- Department of Internal Medicine, National Cancer Center Hospital
-
- ANDO MASASHI
- Department of Internal Medicine, National Cancer Center Hospital
-
- KAWAI AKIRA
- Department of Orthopaedic Surgery, National Cancer Center Hospital
-
- OGOSE AKIRA
- Department of Orthopaedic Surgery, Niigata University
-
- OZAKI TOSHIFUMI
- Department of Orthopaedic Surgery, Okayama University
-
- YOKOYAMA RYOHEI
- Department of Orthopaedic Surgery, Kyusyu Cancer Center
-
- HIRUMA TORU
- Department of Orthopaedic Surgery, Kanagawa Cancer Center
-
- ISHII TAKESHI
- Department of Orthopaedic Surgery, Chiba Cancer Center
-
- MORIOKA HIDEO
- Department of Orthopaedic Surgery, Keio University
-
- MUGISHIMA HIDEO
- Department of Pediatrics, Nihon University
この論文をさがす
収録刊行物
-
- Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
-
Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 15 (5), 654-660, 2010-09-01
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1573105976037560832
-
- NII論文ID
- 10027872091
-
- NII書誌ID
- AA11052566
-
- ISSN
- 09492658
-
- 本文言語コード
- en
-
- データソース種別
-
- CiNii Articles